Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 85
- Companies
Kanabo launches cannabis extract formula for metered dosing
The first cannabis company to IPO on LSE, Kanabo, has launched a new extract formula that will give thousands of UK patients access to pain relief in a metered dose.
- Opinion
Learning From Canada’s Mistakes; Why Firms Should Double Down On Medical Cannabis In Europe
By: Max Monahan-Ellison AS hype and excitement builds around the potential for recreational cannabis legalization in some European countries, it’s an opportune time to share learnings from Canadian recreational legalization and argue that the medical market should remain a priority for companies.
- Medical
Israeli medical cannabis company gets backing from leading healthcare providers
The move suggests that the medical establishment has finally put its faith in cannabis
- Medical
German Medical Cannabis Milestone As First Homegrown Flowers Distributed To Patients
HOMEGROWN medical cannabis is now available to German patients for the first time.
- Pharmaceutical
UK firm signs deal to speed up development of cannabis-based drugs
Oxford Cannabinoid Technologies has signed a deal with drug development firm Evotec as it moves towards Phase 1 clinical trials in humans.
- Medical
First South African medical cannabis flower arrives in UK
It’s been described as a “historic” moment for the sector.
- Medical
Khiron Visualises Brazilian growth after landmark product sale
The European medical cannabis group Khiron is aiming to use its first product sales in Brazil as a launchpad for South American growth.
- CBD Market
CiiTECH Raises Over £2m Ahead Of Its £17.5m London Stock Exchange Debut
CANNABIS company CiiTECH has completed a £2.1m capital raise via an issue of convertible loan notes ahead of its debut on the London Stock Exchange through a reverse takeover (RTO).
- Companies
European Expansion For UK Medical Cannabis Group With Domestic Patient Numbers Set To Hit 300,000
Less than two years after launching, UK-based medical cannabis company LYPHE Group has emerged as a leading player in the patient care field, and now has its sights set on replicating the model in Europe.
- Data & Analysis
Global firm pledges $25 million to fund medical cannabis research
It’s launched a nationwide call for researchers seeking medical cannabis for their studies.
- Pharmaceutical
UK Home Office grants high-THC medical cannabis licence for £300,000 research facility
Construction on the purpose-built facility in Lincolnshire is expected to commence in July.
- Press releases
Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership
Curaleaf International (formerly EMMAC Life Sciences Group), Europe’s largest vertically integrated cannabis company, is pleased to announce that its wholly owned subsidiary, Adven GmbH (“Adven”), has announced a strategic partnership with Zambon GmbH, the German subsidiary of Zambon Spa, an Italian multinational pharmaceutical company, leading in Parkinson’s Diseases, Severe Respiratory Diseases and Pain.
